west virginia glp-1 nausea lawsuit class action in Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs glp-1 nausea class action in
Description
Pendulum Therapeutics latest innovation comes in the form of a GLP-1 probiotic, acting as an appetite suppressor and healthy weight manager.
Rare disorders and disease progression were not examined
The GLP-1 market is projected to exceed 100B USD by 2030
It should be noted that while GLP-1 agonists positively impact metabolism upstream of the liver, this may not subsequently improve the fibrotic liver injury within the tested treatment duration
finalized during chart review
